Evidence map›Paper›PMID 38104162›Full record

ArticleSignal transduction and targeted therapy2023

Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine.

Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George F Gao, Yuliang Zhao, Yaling Wang, Chunying Chen

Erratum issuedOpen access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mengyu Guo *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Mingjing Cao *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0003-1741-3808
Jiufeng Sun *Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
Ziwei ChenCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Xin WangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Lianpan DaiCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Beijing, China.ORCID http://orcid.org/0000-0001-8352-1327
George F GaoCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Beijing, China.ORCID http://orcid.org/0000-0002-3869-615X
Yuliang ZhaoCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Yaling WangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China. wangyl@nanoctr.cn.
Chunying ChenCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China. chenchy@nanoctr.cn.ORCID http://orcid.org/0000-0002-6027-0315
National Center for Nanoscience and Technology · CNInstitute of Microbiology · CNGuangdong Provincial Center for Disease Control and Prevention · CN

Funding

China Postdoctoral Science Foundation 2021TQ0085China Postdoctoral Science Foundation 2022M720932Chinese Academy of Medical Sciences (CAMS) CIFMS 2019-I2M-5-018National Natural Science Foundation of China (National Science Foundation of China) 22027810National Natural Science Foundation of China (National Science Foundation of China) 82341044
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansManganeseManganese

Identifiers

PMID38104162
PMCPMC10725496
OpenAlexW4389831665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.